Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab

Overview of attention for article published in Frontiers in Aging Neuroscience, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 8 news outlets
blogs: 1 blog
twitter: 1 X user

patent: 1 patent
wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 290 Mendeley

Summary News Blogs X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 X post from an account with 218 followers.

@EstebanOrtizMD Al Lecanemab lo vengo siguiendo hace rato. Aún me quedan dudas de su real eficacia en la práctica clínica, pero veamos que resultados sigue arrojando. https://t.co/15Zz6UZwC2

29 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.